ANAGENICS LIMITED - Announcements

0.00%

0.5¢

Market Cap $2.481M

Consumer Defensive Household & Personal Products

Anagenics Limited is an Australia-based health and beauty-tech company that operates... Anagenics Limited is an Australia-based health and beauty-tech company that operates health wellness and beauty business servicing wholesale and retail customers through omnichannel, offering premium branded products. The Company operates through its holding entity, Anagenics Limited and its main operating subsidiary company BLC Cosmetics Pty Limited (BLC) being a distributor of prestige beauty cosmetics and beauty equipment. BLC is an importer and distributor of prestige international and local skin care and wellbeing brands, namely Thalgo, Comfort Zone, Priori and other premium brands. BLC services over 1,000 spas, clinics, salons, retail stores and online in Australia, New Zealand and the Pacific Islands. The Company's brands consist of evolis and Uspa. Evolis is an anti-ageing hair care collection focused on harnessing the scientific research to give customers' thicker and healthier hair.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

AN1	Activity Report & Appendix 4C Q4 FY2025	PRICE SENSITIVE	28/07/25	473.78KB	Share
AN1	YSB Bouf Haircare Continues Strong Performance	PRICE SENSITIVE	27/06/25	42.59KB	Share
AN1	York Street Brands Product Launch	PRICE SENSITIVE	04/06/25	68.99KB	Share
AN1	AN1 - 3Q25 Presentation	PRICE SENSITIVE	05/05/25	3.45MB	Share
AN1	Reinstatement to Quotation	PRICE SENSITIVE	02/05/25	85.48KB	Share
AN1	AN1 - Pre-reinstatement Disclosure	PRICE SENSITIVE	02/05/25	1.08MB	Share
AN1	AN1 3Q25 Activity Report	PRICE SENSITIVE	02/05/25	41.89KB	Share
AN1	Appendix 4C Cash Flow Report	PRICE SENSITIVE	01/05/25	234.52KB	Share
AN1	Long Term Suspended Entities	PRICE SENSITIVE	09/04/25	204.98KB	Share
AN1	AN1 - 1H25 Update	PRICE SENSITIVE	28/02/25	148.58KB	Share
AN1	AN1 - Appendix 4D 1H FY2025	PRICE SENSITIVE	27/02/25	318.92KB	Share
AN1	Update on 2Q25 Activity Report	PRICE SENSITIVE	10/02/25	414.19KB	Share
AN1	Q2 F25 Activity Statement and Appendix 4C	PRICE SENSITIVE	31/01/25	697.03KB	Share
AN1	Long Term Suspended Entities	PRICE SENSITIVE	22/01/25	201.08KB	Share
AN1	Restructuring Update & Resignation of Director	PRICE SENSITIVE	31/10/24	466.74KB	Share
AN1	Q1 F25 Activity Statement and Appendix 4C	PRICE SENSITIVE	31/10/24	830.16KB	Share
AN1	Market Update	PRICE SENSITIVE	02/10/24	449.73KB	Share
AN1	Suspension from Official Quotation	PRICE SENSITIVE	04/09/24	848.88KB	Share
AN1	Trading Halt	PRICE SENSITIVE	02/09/24	482.27KB	Share
AN1	Pause in Trading	PRICE SENSITIVE	02/09/24	112.85KB	Share
AN1	FY24 4E Presentation	PRICE SENSITIVE	30/08/24	11.24MB	Share
AN1	Appendix 4E and Preliminary Final Report	PRICE SENSITIVE	30/08/24	976.44KB	Share
AN1	Company Update License Partnership Announcement	PRICE SENSITIVE	24/07/24	154.39KB	Share
AN1	Appendix 4C Cash Flow & Activities Report	PRICE SENSITIVE	24/07/24	304.48KB	Share
AN1	Midkine Antibody Licensing Deal	PRICE SENSITIVE	24/05/24	749.91KB	Share
AN1	Trading Halt	PRICE SENSITIVE	24/05/24	197.19KB	Share
AN1	Pause in Trading	PRICE SENSITIVE	24/05/24	116.75KB	Share
AN1	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/24	348.8KB	Share
AN1	Organisational Changes	PRICE SENSITIVE	08/03/24	140.78KB	Share
AN1	H1 FY24 Results and Corporate Update	PRICE SENSITIVE	27/02/24	174.66KB	Share
AN1	Appendix 4D and Half Year Report	PRICE SENSITIVE	27/02/24	758.83KB	Share
AN1	Investor Presentation	PRICE SENSITIVE	07/02/24	1.32MB	Share
AN1	Completion of Placement	PRICE SENSITIVE	07/02/24	139.37KB	Share
AN1	Trading Halt	PRICE SENSITIVE	05/02/24	141.13KB	Share
AN1	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/24	333.05KB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	31/10/23	318KB	Share
AN1	Business Update	PRICE SENSITIVE	02/10/23	131.46KB	Share
AN1	Appendix 4E and Preliminary Final Report	PRICE SENSITIVE	30/08/23	1.15MB	Share
AN1	Acquisition of Face MediGroup Presentation	PRICE SENSITIVE	22/08/23	1.35MB	Share
AN1	Anagenics to Acquire Face MediGroup	PRICE SENSITIVE	22/08/23	159.52KB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	31/07/23	353.51KB	Share
AN1	FY23 Financial Performance and Business Update	PRICE SENSITIVE	27/06/23	161.12KB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	28/04/23	365.55KB	Share
AN1	CEO Appointment	PRICE SENSITIVE	29/03/23	137.35KB	Share
AN1	Results of Institutional Entitlement Offer	PRICE SENSITIVE	16/02/23	175.18KB	Share
AN1	Investor Presentation	PRICE SENSITIVE	14/02/23	1.85MB	Share
AN1	Entitlement Offer and Company Update	PRICE SENSITIVE	14/02/23	334.88KB	Share
AN1	Trading Halt	PRICE SENSITIVE	14/02/23	512.14KB	Share
AN1	Appendix 4D and Half Year Report	PRICE SENSITIVE	13/02/23	915.51KB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	25/01/23	373.02KB	Share
AN1	Corporate Update and Acquisition	PRICE SENSITIVE	09/12/22	142KB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	26/10/22	319.42KB	Share
AN1	Appendix 4E and FY22 Financial Report	PRICE SENSITIVE	25/08/22	1.99MB	Share
AN1	Advangen Japan Divestment and Earn-Out Agreement	PRICE SENSITIVE	26/07/22	170.14KB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	26/07/22	323.61KB	Share
AN1	Appointment of Exec Director, Corporate and Trading Update	PRICE SENSITIVE	08/07/22	196.68KB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	28/04/22	285.66KB	Share
AN1	New Leadership Driving Business Transformation	PRICE SENSITIVE	16/03/22	143.64KB	Share
AN1	Anagenics Appoints CEO	PRICE SENSITIVE	01/03/22	140.48KB	Share
AN1	Appendix 4D and Half Year Report	PRICE SENSITIVE	15/02/22	353.62KB	Share
AN1	Anagenics Board and Leadership Transition	PRICE SENSITIVE	15/02/22	91KB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	28/01/22	290.81KB	Share
AN1	Second Supply Agreement for Anagenics' FGF5 Inhibitors	PRICE SENSITIVE	24/12/21	206.47KB	Share
AN1	BLC Cosmetics Acquisition Completed	PRICE SENSITIVE	02/11/21	83.19KB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	20/10/21	321.33KB	Share
AN1	Investor Webinar	PRICE SENSITIVE	27/09/21	1.9MB	Share
AN1	HNG: BLC Cosmetics to merge with Cellmid	PRICE SENSITIVE	16/09/21	159.83KB	Share
AN1	Cellmid to Acquire BLC Cosmetics Pty Ltd	PRICE SENSITIVE	16/09/21	135.96KB	Share
AN1	Appendix 4E and FY21 Financial Report	PRICE SENSITIVE	19/08/21	1.22MB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	20/07/21	350.86KB	Share
AN1	Cellmid Reports Record QVC Sales	PRICE SENSITIVE	17/06/21	182.91KB	Share
AN1	Supply Agreement for Cellmid's FGF5 Inhibitors	PRICE SENSITIVE	08/06/21	121.97KB	Share
AN1	Chinese Import Permits Received	PRICE SENSITIVE	30/04/21	108.95KB	Share
AN1	Agreement Signed for Sale of Lyramid Limited	PRICE SENSITIVE	29/04/21	128.53KB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	23/04/21	276.22KB	Share
AN1	Supplementary Prospectus	PRICE SENSITIVE	31/03/21	337.55KB	Share
AN1	Rights Issue Closed with Strong Demand	PRICE SENSITIVE	31/03/21	97.9KB	Share
AN1	Rights Issue Prospectus	PRICE SENSITIVE	08/03/21	500.4KB	Share
AN1	Rights Issue	PRICE SENSITIVE	08/03/21	87.55KB	Share
AN1	Pause in Trading	PRICE SENSITIVE	08/03/21	115.08KB	Share
AN1	Appendix 4D and Half Year Report	PRICE SENSITIVE	18/02/21	894.7KB	Share
AN1	Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer	PRICE SENSITIVE	09/02/21	79.99KB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	25/01/21	379.06KB	Share
AN1	Cellmid Receives First Order From Chinese Distributor	PRICE SENSITIVE	25/01/21	59.56KB	Share
AN1	Cellmid Signs 10 Year Chinese Distribution Agreement	PRICE SENSITIVE	14/12/20	75.78KB	Share
AN1	Growth Strategy Presentation	PRICE SENSITIVE	12/11/20	1.65MB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	22/10/20	279.51KB	Share
AN1	FY20 Financial Results	PRICE SENSITIVE	27/08/20	73.95KB	Share
AN1	Appendix 4E and FY20 Financial Report	PRICE SENSITIVE	27/08/20	1.34MB	Share
AN1	CDY Signs Agreement With Premium Salon Distributor in USA	PRICE SENSITIVE	28/07/20	75.8KB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	22/07/20	391.46KB	Share
AN1	Response to ASX Aware Query	PRICE SENSITIVE	09/07/20	218.16KB	Share
AN1	Cellmid Signs Exclusive Agreement For Sars-Cov-2 Laboratory	PRICE SENSITIVE	09/07/20	102.44KB	Share
AN1	Trading Halt	PRICE SENSITIVE	07/07/20	189.6KB	Share
AN1	Pause in Trading	PRICE SENSITIVE	07/07/20	113.64KB	Share
AN1	Extension Of Wondfo Rapid Test Distribution Agreement	PRICE SENSITIVE	02/07/20	84.81KB	Share
AN1	Cellmid Reports on Strong QVC Sales Event	PRICE SENSITIVE	16/06/20	74.79KB	Share
AN1	Reinstatement to Official Quotation	PRICE SENSITIVE	15/06/20	86.79KB	Share
AN1	Cellmid Reports on Results of The Doherty Institute Testing	PRICE SENSITIVE	15/06/20	147.69KB	Share
AN1	CDY signs Introducer Agreement to broaden product offering	PRICE SENSITIVE	04/06/20	161.98KB	Share

AN1 Activity Report & Appendix 4C Q4 FY2025
28/07/25	PRICE SENSITIVE	473.78KB	Share
AN1 YSB Bouf Haircare Continues Strong Performance
27/06/25	PRICE SENSITIVE	42.59KB	Share
AN1 York Street Brands Product Launch
04/06/25	PRICE SENSITIVE	68.99KB	Share
AN1 AN1 - 3Q25 Presentation
05/05/25	PRICE SENSITIVE	3.45MB	Share
AN1 Reinstatement to Quotation
02/05/25	PRICE SENSITIVE	85.48KB	Share
AN1 AN1 - Pre-reinstatement Disclosure
02/05/25	PRICE SENSITIVE	1.08MB	Share
AN1 AN1 3Q25 Activity Report
02/05/25	PRICE SENSITIVE	41.89KB	Share
AN1 Appendix 4C Cash Flow Report
01/05/25	PRICE SENSITIVE	234.52KB	Share
AN1 Long Term Suspended Entities
09/04/25	PRICE SENSITIVE	204.98KB	Share
AN1 AN1 - 1H25 Update
28/02/25	PRICE SENSITIVE	148.58KB	Share
AN1 AN1 - Appendix 4D 1H FY2025
27/02/25	PRICE SENSITIVE	318.92KB	Share
AN1 Update on 2Q25 Activity Report
10/02/25	PRICE SENSITIVE	414.19KB	Share
AN1 Q2 F25 Activity Statement and Appendix 4C
31/01/25	PRICE SENSITIVE	697.03KB	Share
AN1 Long Term Suspended Entities
22/01/25	PRICE SENSITIVE	201.08KB	Share
AN1 Restructuring Update & Resignation of Director
31/10/24	PRICE SENSITIVE	466.74KB	Share
AN1 Q1 F25 Activity Statement and Appendix 4C
31/10/24	PRICE SENSITIVE	830.16KB	Share
AN1 Market Update
02/10/24	PRICE SENSITIVE	449.73KB	Share
AN1 Suspension from Official Quotation
04/09/24	PRICE SENSITIVE	848.88KB	Share
AN1 Trading Halt
02/09/24	PRICE SENSITIVE	482.27KB	Share
AN1 Pause in Trading
02/09/24	PRICE SENSITIVE	112.85KB	Share
AN1 FY24 4E Presentation
30/08/24	PRICE SENSITIVE	11.24MB	Share
AN1 Appendix 4E and Preliminary Final Report
30/08/24	PRICE SENSITIVE	976.44KB	Share
AN1 Company Update License Partnership Announcement
24/07/24	PRICE SENSITIVE	154.39KB	Share
AN1 Appendix 4C Cash Flow & Activities Report
24/07/24	PRICE SENSITIVE	304.48KB	Share
AN1 Midkine Antibody Licensing Deal
24/05/24	PRICE SENSITIVE	749.91KB	Share
AN1 Trading Halt
24/05/24	PRICE SENSITIVE	197.19KB	Share
AN1 Pause in Trading
24/05/24	PRICE SENSITIVE	116.75KB	Share
AN1 Quarterly Activities/Appendix 4C Cash Flow Report
29/04/24	PRICE SENSITIVE	348.8KB	Share
AN1 Organisational Changes
08/03/24	PRICE SENSITIVE	140.78KB	Share
AN1 H1 FY24 Results and Corporate Update
27/02/24	PRICE SENSITIVE	174.66KB	Share
AN1 Appendix 4D and Half Year Report
27/02/24	PRICE SENSITIVE	758.83KB	Share
AN1 Investor Presentation
07/02/24	PRICE SENSITIVE	1.32MB	Share
AN1 Completion of Placement
07/02/24	PRICE SENSITIVE	139.37KB	Share
AN1 Trading Halt
05/02/24	PRICE SENSITIVE	141.13KB	Share
AN1 Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24	PRICE SENSITIVE	333.05KB	Share
AN1 Appendix 4C and Quarterly Activity Report
31/10/23	PRICE SENSITIVE	318KB	Share
AN1 Business Update
02/10/23	PRICE SENSITIVE	131.46KB	Share
AN1 Appendix 4E and Preliminary Final Report
30/08/23	PRICE SENSITIVE	1.15MB	Share
AN1 Acquisition of Face MediGroup Presentation
22/08/23	PRICE SENSITIVE	1.35MB	Share
AN1 Anagenics to Acquire Face MediGroup
22/08/23	PRICE SENSITIVE	159.52KB	Share
AN1 Appendix 4C and Quarterly Activity Report
31/07/23	PRICE SENSITIVE	353.51KB	Share
AN1 FY23 Financial Performance and Business Update
27/06/23	PRICE SENSITIVE	161.12KB	Share
AN1 Appendix 4C and Quarterly Activity Report
28/04/23	PRICE SENSITIVE	365.55KB	Share
AN1 CEO Appointment
29/03/23	PRICE SENSITIVE	137.35KB	Share
AN1 Results of Institutional Entitlement Offer
16/02/23	PRICE SENSITIVE	175.18KB	Share
AN1 Investor Presentation
14/02/23	PRICE SENSITIVE	1.85MB	Share
AN1 Entitlement Offer and Company Update
14/02/23	PRICE SENSITIVE	334.88KB	Share
AN1 Trading Halt
14/02/23	PRICE SENSITIVE	512.14KB	Share
AN1 Appendix 4D and Half Year Report
13/02/23	PRICE SENSITIVE	915.51KB	Share
AN1 Appendix 4C and Quarterly Activity Report
25/01/23	PRICE SENSITIVE	373.02KB	Share
AN1 Corporate Update and Acquisition
09/12/22	PRICE SENSITIVE	142KB	Share
AN1 Appendix 4C and Quarterly Activity Report
26/10/22	PRICE SENSITIVE	319.42KB	Share
AN1 Appendix 4E and FY22 Financial Report
25/08/22	PRICE SENSITIVE	1.99MB	Share
AN1 Advangen Japan Divestment and Earn-Out Agreement
26/07/22	PRICE SENSITIVE	170.14KB	Share
AN1 Appendix 4C and Quarterly Activity Report
26/07/22	PRICE SENSITIVE	323.61KB	Share
AN1 Appointment of Exec Director, Corporate and Trading Update
08/07/22	PRICE SENSITIVE	196.68KB	Share
AN1 Appendix 4C and Quarterly Activity Report
28/04/22	PRICE SENSITIVE	285.66KB	Share
AN1 New Leadership Driving Business Transformation
16/03/22	PRICE SENSITIVE	143.64KB	Share
AN1 Anagenics Appoints CEO
01/03/22	PRICE SENSITIVE	140.48KB	Share
AN1 Appendix 4D and Half Year Report
15/02/22	PRICE SENSITIVE	353.62KB	Share
AN1 Anagenics Board and Leadership Transition
15/02/22	PRICE SENSITIVE	91KB	Share
AN1 Appendix 4C and Quarterly Activity Report
28/01/22	PRICE SENSITIVE	290.81KB	Share
AN1 Second Supply Agreement for Anagenics' FGF5 Inhibitors
24/12/21	PRICE SENSITIVE	206.47KB	Share
AN1 BLC Cosmetics Acquisition Completed
02/11/21	PRICE SENSITIVE	83.19KB	Share
AN1 Appendix 4C and Quarterly Activity Report
20/10/21	PRICE SENSITIVE	321.33KB	Share
AN1 Investor Webinar
27/09/21	PRICE SENSITIVE	1.9MB	Share
AN1 HNG: BLC Cosmetics to merge with Cellmid
16/09/21	PRICE SENSITIVE	159.83KB	Share
AN1 Cellmid to Acquire BLC Cosmetics Pty Ltd
16/09/21	PRICE SENSITIVE	135.96KB	Share
AN1 Appendix 4E and FY21 Financial Report
19/08/21	PRICE SENSITIVE	1.22MB	Share
AN1 Appendix 4C and Quarterly Activity Report
20/07/21	PRICE SENSITIVE	350.86KB	Share
AN1 Cellmid Reports Record QVC Sales
17/06/21	PRICE SENSITIVE	182.91KB	Share
AN1 Supply Agreement for Cellmid's FGF5 Inhibitors
08/06/21	PRICE SENSITIVE	121.97KB	Share
AN1 Chinese Import Permits Received
30/04/21	PRICE SENSITIVE	108.95KB	Share
AN1 Agreement Signed for Sale of Lyramid Limited
29/04/21	PRICE SENSITIVE	128.53KB	Share
AN1 Appendix 4C and Quarterly Activity Report
23/04/21	PRICE SENSITIVE	276.22KB	Share
AN1 Supplementary Prospectus
31/03/21	PRICE SENSITIVE	337.55KB	Share
AN1 Rights Issue Closed with Strong Demand
31/03/21	PRICE SENSITIVE	97.9KB	Share
AN1 Rights Issue Prospectus
08/03/21	PRICE SENSITIVE	500.4KB	Share
AN1 Rights Issue
08/03/21	PRICE SENSITIVE	87.55KB	Share
AN1 Pause in Trading
08/03/21	PRICE SENSITIVE	115.08KB	Share
AN1 Appendix 4D and Half Year Report
18/02/21	PRICE SENSITIVE	894.7KB	Share
AN1 Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer
09/02/21	PRICE SENSITIVE	79.99KB	Share
AN1 Appendix 4C and Quarterly Activity Report
25/01/21	PRICE SENSITIVE	379.06KB	Share
AN1 Cellmid Receives First Order From Chinese Distributor
25/01/21	PRICE SENSITIVE	59.56KB	Share
AN1 Cellmid Signs 10 Year Chinese Distribution Agreement
14/12/20	PRICE SENSITIVE	75.78KB	Share
AN1 Growth Strategy Presentation
12/11/20	PRICE SENSITIVE	1.65MB	Share
AN1 Appendix 4C and Quarterly Activity Report
22/10/20	PRICE SENSITIVE	279.51KB	Share
AN1 FY20 Financial Results
27/08/20	PRICE SENSITIVE	73.95KB	Share
AN1 Appendix 4E and FY20 Financial Report
27/08/20	PRICE SENSITIVE	1.34MB	Share
AN1 CDY Signs Agreement With Premium Salon Distributor in USA
28/07/20	PRICE SENSITIVE	75.8KB	Share
AN1 Appendix 4C and Quarterly Activity Report
22/07/20	PRICE SENSITIVE	391.46KB	Share
AN1 Response to ASX Aware Query
09/07/20	PRICE SENSITIVE	218.16KB	Share
AN1 Cellmid Signs Exclusive Agreement For Sars-Cov-2 Laboratory
09/07/20	PRICE SENSITIVE	102.44KB	Share
AN1 Trading Halt
07/07/20	PRICE SENSITIVE	189.6KB	Share
AN1 Pause in Trading
07/07/20	PRICE SENSITIVE	113.64KB	Share
AN1 Extension Of Wondfo Rapid Test Distribution Agreement
02/07/20	PRICE SENSITIVE	84.81KB	Share
AN1 Cellmid Reports on Strong QVC Sales Event
16/06/20	PRICE SENSITIVE	74.79KB	Share
AN1 Reinstatement to Official Quotation
15/06/20	PRICE SENSITIVE	86.79KB	Share
AN1 Cellmid Reports on Results of The Doherty Institute Testing
15/06/20	PRICE SENSITIVE	147.69KB	Share
AN1 CDY signs Introducer Agreement to broaden product offering
04/06/20	PRICE SENSITIVE	161.98KB	Share

REFRESH

1 2 3

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.5¢		Change 0.000(0.00%)		Mkt cap ! $2.481M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
3	1596000	0.5¢

Sellers (Offers)

Price($)	Vol.	No.
0.6¢	207362	1

View Market Depth

No.	Vol.	Price($)
3	1596000	0.005
7	7865199	0.004
3	5450000	0.003
2	2800000	0.002
3	2600000	0.001

Price($)	Vol.	No.
0.006	207362	1
0.007	125000	1
0.008	1323713	4
0.009	620000	2
0.010	500000	1

Last trade - 16.21pm 31/07/2025 (20 minute delay)

AN1 (ASX) Chart

Day chart unavailable

ANAGENICS LIMITED - Announcements

Corporate Spotlight
Not Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories

ANAGENICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

Top Stories

Corporate Spotlight
Not Yet Available